rolipram and glucagon
rolipram has been researched along with glucagon in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Absood, A; Chen, D; Håkanson, R | 1 |
| Azizeh, BY; Houslay, MD; Hruby, VJ; Johnson, DG; Phelps, JR; Trivedi, D; Van Tine, BA | 1 |
| Azizeh, BY; Hruby, VJ; Trivedi, D; Van Tine, BA | 1 |
| Beavo, JA; Bornfeldt, KE; Zhao, AZ | 1 |
| Hernández Cascales, J; Juan-Fita, MJ; Kaumann, AJ; Vargas, ML | 1 |
Other Studies
5 other study(ies) available for rolipram and glucagon
| Article | Year |
|---|---|
Neuropeptides of the vasoactive intestinal peptide/helodermin/pituitary adenylate cyclase activating peptide family elevate plasma cAMP in mice: comparison with a range of other regulatory peptides.
Topics: Animals; Calcitonin; Calcitonin Gene-Related Peptide; Colforsin; Cyclic AMP; Drug Interactions; Glucagon; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Mice; Neuropeptides; Parathyroid Hormone; Peptides; Phosphodiesterase Inhibitors; Pyrrolidinones; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Rolipram; Tail; Vasoactive Intestinal Peptide | 1992 |
Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists.
Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclase Inhibitors; Amrinone; Animals; Blood Glucose; Cyclic AMP; Diabetes Mellitus, Experimental; Glucagon; Liver; Male; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Rolipram | 1996 |
Pure glucagon antagonists: biological activities and cAMP accumulation using phosphodiesterase inhibitors.
Topics: Adenylyl Cyclases; Animals; Cattle; Cyclic AMP; Glucagon; Humans; Liver; Male; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Rolipram; Sensitivity and Specificity | 1997 |
Leptin inhibits insulin secretion by activation of phosphodiesterase 3B.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Androstadienes; Animals; Cell Line; Chromones; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Enzyme Activation; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Leptin; Morpholines; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphatidylinositol Phosphates; Phosphoinositide-3 Kinase Inhibitors; Protein Precursors; Proteins; Pyrrolidinones; Rats; Rolipram; Signal Transduction; Wortmannin | 1998 |
Rolipram reduces the inotropic tachyphylaxis of glucagon in rat ventricular myocardium.
Topics: Animals; Cardiotonic Agents; Dose-Response Relationship, Drug; Female; Glucagon; Heart Ventricles; In Vitro Techniques; Male; Myocardial Contraction; Rats; Rats, Sprague-Dawley; Rolipram; Tachyphylaxis; Ventricular Function | 2004 |